- Latest news▼
-
12:16, April 19 Scientists grow human mini-lungs in lab
-
10:23, April 19 JAMA Oncology: Urine test can help rule out high-grade prostate cancer with almost 100% accuracy, study shows
-
18:00, April 18 Daily Mail: Elderly woman in China gets infected with brain-eating amoeba
-
14:19, April 18 Obesity: exercising before breakfast helps you lose weight faster
-
10:42, April 18 The Conversation: childhood trauma can cause pathological hoarding
-
08:37, April 18 Daily Mail: Satiating food reduces cravings for sweets, nutritionist says
-
18:22, April 17 First Armenian-German Conference entitled “Heart Failure Spring School”
-
08:38, April 17 Why do kids usually recover from COVID-19 more easily than adults?
-
14:37, April 16 Daily Mail: intermittent fasting is not suitable for children and women before their periods
-
16:41, April 15 Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk
-
15:04, April 15 305 cases of measles recorded in Armenia so far in 2024
-
14:38, April 15 Food and Environmental Virology: tea contributes to effective coronavirus control
-
12:41, April 15 Daily Mail: vitamin A, B3 and E supplements can be dangerous
-
10:56, April 15 Diabetes Care: evening physical activity is good for the heart
-
08:27, April 15 Women are more susceptible to blood loss and death during bypass surgery than men, researchers say
All materials
Antibody injection may be effective as protection against COVID-19
An antibody injection that provides quick protection against COVID-19 may be ready as early as next year, according to pharmaceutical giant AstraZeneca.
According to The Daily Mail, the new development of AstraZeneca is an injection solution that contains 'cloned antibodies' - proteins that know how to fight the virus. With this injection, the human body will receive the necessary antibodies that will help overcome the disease.
The company says the injection would be prioritized for the elderly, since vaccines may not be particularly effective for them. The fact is that vaccines contribute to the production of antibodies in response to infection. However, in the elderly, this mechanism produces fewer antibodies.
The new development is a combination of two antibodies, which reduces the risk of resistance. According to scientists, monoclonal antibodies have previously been used to treat diphtheria, tetanus, and Ebola.
Many international groups of scientists are now looking for effective antibodies for the new COVID-19, but so far there are few such drugs in clinical trials. According to scientists, the introduction of antibodies at the earliest stage of infection provides to stop the destructive effect of the virus, not allowing it to cause serious illness.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- WHO: Nigeria pioneers revolutionary meningitis vaccine 1179
- One-third of women experience menstruation-related migraines, most often during premenopause - study 1161
- Daily Mail: vitamin A, B3 and E supplements can be dangerous 998
- Food and Environmental Virology: tea contributes to effective coronavirus control 995
- Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk 967
- Women are more susceptible to blood loss and death during bypass surgery than men, researchers say 961
- 305 cases of measles recorded in Armenia so far in 2024 959
- Diabetes Care: evening physical activity is good for the heart 921
- Daily Mail: intermittent fasting is not suitable for children and women before their periods 776
- First Armenian-German Conference entitled “Heart Failure Spring School” 561
- Why do kids usually recover from COVID-19 more easily than adults? 442
- The Conversation: childhood trauma can cause pathological hoarding 440
- Obesity: exercising before breakfast helps you lose weight faster 439
- Daily Mail: Elderly woman in China gets infected with brain-eating amoeba 402
- Daily Mail: Satiating food reduces cravings for sweets, nutritionist says 399
- Find us on Facebook
- Poll